Sustainable development for the healthcare industry : reprogramming the healthcare value chain /: reprogramming the healthcare value chain. ([2014])

• Record Type: Book
• Further Information: Note: Pierre A. Morgon, editor.
• Editors: Morgon, Pierre A
• Contents: About the Editor and Contributors; Chapter-1; Sustainable Development for the Health-Care Industry: Setting the Stage; Human Society Has Always Been Focused on Health; The Mission of the Health-Care Industry; The Life Cycle of Pharmaceutical Products; The Mega Trends Which Affect the Health-Care Industry; Societal Expectations for Personalized Medicine; The DNA of the Health-Care Industry: Evolving Management of Innovation; Sustainability and Pharmaceutical Products: Role in Human Health (Mistra Pharma 2009). Pharmaceutical Products and Contribution to Global Health: Global Health Requires More than Better DrugsSustainable Concerns All Along the Life Cycle of the Health-care Industry; R & D; Manufacturing and Supply Chain; Licensing and Market Access; Consumption of Health-Care Products: Use, Access, and Disease Management; Global Corporate Governance; Conclusion; References; Chapter-2; Can Innovation Still Be the Main Growth Driver of the Pharmaceutical Industry?; Innovation as a Driver of Growth for the Pharmaceutical Industry in the Past; The Pharmaceutical Industry Today. The R & D Investments of Top Pharmaceutical CompaniesThe Output of Pharmaceutical R & D; The Pharmaceutical Innovation Process; The Success Rates of Pharmaceutical R & D; The Timelines of Pharmaceutical R & D; The Cost of Pharmaceutical R & D; A Steady-State R & D Model; The Reduced R & D Efficiency; Consequences of the Reduced R & D Efficiency; Increasing the Number of Projects in the R & D Pipeline; Reducing Costs of R & D; Measuring Performance and Managing the Project Portfolio Actively; Opening R & D Towards External Innovation; Sustainable Growth in Times of Reduced R & D Efficiency. Increasing Pressure from Generic DrugsSustainability Must Come from R & D; References; The Importance of Understanding the 'Lived Experience' of Patients in Pharmaceutical Development Programmes; Chapter-3; Introduction; How Can We Make Sure We Look Beyond the Science and Capture the 'Human Being' in Our Data?; Is the Pharmaceutical Industry Brave Enough to Let Patients Contribute to Driving the Research Agenda?; So How Do We Facilitate This?; How Can We Benefit From This Sort of Research?; Building the Value Chain With Patients Playing a Key Role; So What Can We Do to Drive Change? Why Bother?Chapter-4; Listening to the Voice of the Patient to Facilitate Earlier Access to Promising Medicines: Interview with Sjaak Vink; Chapter-5; Drivers of the Real-World Data Revolution and the Transition to Adaptive Licensing: Interview with Dr. Richard Barker; CASMI (Center for the Advancement of Sustainable Medical Innovation); Chapter-6; Sustainable Development for the Healthcare Industry: Vantage Point from Emerging Economies; Introduction; Sustainable Commercialization; Roles Played by MNCs Versus Local Manufacturers in Emerging Economies; Vantage Point; Regulations.
• Publisher Details: Cham : Springer
• Publication Date: 2014
• Copyright Date: 2015
• Extent: 1 online resource (x, 154 pages), color illustrations
• Subjects: 338.4/73621; Business; Medical economics; Sustainable development; Health Care Sector -- economics; BUSINESS & ECONOMICS -- Industries -- General; Medical economics; Sustainable development; Business & Economics -- Production & Operations Management; Science -- Environmental Science; Management of specific areas; Research & development management; Sustainability; Management science; Health care management; Production management; Management; Medical -- Administration; Health economics; Electronic books
• Languages: English
• ISBNs: 9783319125268; 3319125265; 3319125257; 9783319125251
• Related ISBNs: 9783319125251
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed December 31, 2014).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.